Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

Jun 18 • 04:00PM ET

88.34

+0.85 0.97 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	10.85%	Shs Outstand	78.84M	Perf Week	9.37%
Market Cap	7.67B	Forward P/E	-	EPS next Y	-3.20	Insider Trans	-3.03%	Shs Float	77.42M	Perf Month	32.60%
Enterprise Value	7.09B	PEG	-	EPS next Q	-0.76	Inst Own	87.15%	Short Float	16.31%	Perf Quarter	108.79%
Income	-168.74M	P/S	-	EPS this Y	-52.10%	Inst Trans	1.15%	Short Ratio	10.73	Perf Half Y	167.94%
Sales	0.00M	P/B	13.52	EPS next Y	-6.28%	ROA	-25.30%	Short Interest	12.63M	Perf YTD	169.66%
Book/sh	6.53	P/C	10.35	EPS next 5Y	-23.44%	ROE	-29.26%	52W High	88.03 0.35%	Perf Year	485.81%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	14.00 531.00%	Perf 3Y	2429.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.96% 5.82%	Perf 5Y	-45.13%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.54	Perf 10Y	-20.77%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	69.44	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	15.22%	Beta	3.00	Target Price	99.13
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	21.46%	Rel Volume	2.06	Prev Close	87.49
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	116.05%	Avg Volume	1.18M	Price	88.34
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	2,420,415	Change	0.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)